• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异位肾患嫌色细胞肾细胞癌行部分肾切除术后不可预测的复发:病例报告及文献复习

Unpredictable recurrence following partial nephrectomy for chromophobe renal cell carcinoma on an ectopic kidney: Case report and review of literature.

作者信息

El Aboudi Adam, Lakssir Jihad, Boualaoui Imad, Ibrahimi Ahmed, El-Sayegh Hachem, Nouini Yassine

机构信息

Department of Urology A, Ibn Sina Hospital, University of Rabat, Morocco.

出版信息

Int J Surg Case Rep. 2024 Sep;122:110118. doi: 10.1016/j.ijscr.2024.110118. Epub 2024 Aug 3.

DOI:10.1016/j.ijscr.2024.110118
PMID:39126935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367142/
Abstract

INTRODUCTION

Renal cell carcinoma is one of the 10 most common malignancies. Partial nephrectomy (PN) is the preferred treatment for localized ones. The incidence of local recurrence (LR) after a PN varies between zero and 17% in the literature. Managing a LR following PN is a challenging situation, both ablation therapy and salvage surgery are viable options.

CASE PRESENTATION

A 38-year-old woman with a history of a right open partial nephrectomy performed on an ectopic kidney four years ago, presented a loco regional recurrence, involving the right ovary and rectus muscle, which we managed by a radical nephrectomy with bilateral oophorectomy et resection of the rectus muscle nodules.

CLINICAL DISCUSSION

LR of RCC after PN presents a clinically challenging scenario. Treatment options include ablative therapy or surgical salvage therapy, which can be either by radical nephrectomy or by repeat partial nephrectomy. Ablative therapy has less complication rate and is preferred for small LR or on a solitary kidney. Repeat PN is also an option for preserving renal function but with high risk of complication. RN is an option if PN is technically challenging, especially in patients with a functional contralateral kidney.

CONCLUSION

Recurrent renal cell carcinoma (RCC) can manifest differently based on the primary treatment, as well as tumor and patient characteristics. Managing a LR following PN is a challenging situation, both ablation therapy and salvage surgery are viable options.

摘要

引言

肾细胞癌是十大常见恶性肿瘤之一。部分肾切除术(PN)是局限性肾细胞癌的首选治疗方法。文献中报道PN术后局部复发(LR)的发生率在0%至17%之间。处理PN术后的LR是一种具有挑战性的情况,消融治疗和挽救性手术都是可行的选择。

病例介绍

一名38岁女性,四年前因异位肾接受了右侧开放性部分肾切除术,现出现局部区域复发,累及右侧卵巢和腹直肌,我们通过根治性肾切除术、双侧卵巢切除术及腹直肌结节切除术进行治疗。

临床讨论

PN术后肾细胞癌的LR是一种具有临床挑战性的情况。治疗选择包括消融治疗或手术挽救治疗,后者可以是根治性肾切除术或再次部分肾切除术。消融治疗的并发症发生率较低,对于小的LR或单肾患者更为适用。再次PN也是保留肾功能的一种选择,但并发症风险较高。如果PN在技术上具有挑战性,尤其是对于对侧肾功能正常的患者,根治性肾切除术是一种选择。

结论

复发性肾细胞癌(RCC)根据初始治疗、肿瘤及患者特征的不同可表现各异。处理PN术后的LR是一种具有挑战性的情况,消融治疗和挽救性手术都是可行的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/f70619c1c23c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/9841e12e1bb3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/636b14ca655b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/fcdc30c04e56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/08a7f56b85c6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/f70619c1c23c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/9841e12e1bb3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/636b14ca655b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/fcdc30c04e56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/08a7f56b85c6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11367142/f70619c1c23c/gr5.jpg

相似文献

1
Unpredictable recurrence following partial nephrectomy for chromophobe renal cell carcinoma on an ectopic kidney: Case report and review of literature.异位肾患嫌色细胞肾细胞癌行部分肾切除术后不可预测的复发:病例报告及文献复习
Int J Surg Case Rep. 2024 Sep;122:110118. doi: 10.1016/j.ijscr.2024.110118. Epub 2024 Aug 3.
2
Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.孤立肾中 cT1 期肾肿瘤的热消融与部分肾切除术:一项匹配队列比较分析。
Ann Surg Oncol. 2024 Mar;31(3):2133-2143. doi: 10.1245/s10434-023-14646-2. Epub 2023 Dec 10.
3
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较:系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
4
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).肾细胞癌部分肾切除术后局部复发的经皮消融与手术切除:倾向评分分析(REPART研究-UroCCR 71)
Eur Urol Focus. 2022 Jan;8(1):210-216. doi: 10.1016/j.euf.2021.02.007. Epub 2021 Feb 20.
5
Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes.机器人辅助肾部分切除术治疗肾部分切除术后或肾肿瘤消融后局部复发:分类、技术和临床结果。
Eur Urol. 2021 Dec;80(6):730-737. doi: 10.1016/j.eururo.2021.04.003. Epub 2021 Jun 2.
6
Incidence and predictors of ipsilateral local recurrence following partial nephrectomy.部分肾切除术治疗后同侧局部复发的发生率和预测因素。
Urol Oncol. 2024 Oct;42(10):334.e1-334.e9. doi: 10.1016/j.urolonc.2024.05.004. Epub 2024 Jun 29.
7
Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy.肾部分切除术后诊断和处理手术切缘阳性及局部复发的当前策略。
Asian J Urol. 2022 Jul;9(3):227-242. doi: 10.1016/j.ajur.2022.06.002. Epub 2022 Jun 14.
8
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.pT3a 病理分期上调的肾细胞癌行根治性和部分肾切除术的肿瘤学及功能结局:一项多机构分析
Clin Genitourin Cancer. 2020 Dec;18(6):e723-e729. doi: 10.1016/j.clgc.2020.05.002. Epub 2020 May 11.
9
Comprehensive Management of Renal Masses in Solitary Kidneys.孤立肾肾肿瘤的综合管理。
Eur Urol Oncol. 2023 Feb;6(1):84-94. doi: 10.1016/j.euo.2022.11.004. Epub 2022 Dec 12.
10
Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.经皮消融与部分和根治性肾切除术治疗 T1a 期肾癌:基于人群的分析。
Ann Intern Med. 2018 Jul 17;169(2):69-77. doi: 10.7326/M17-0585. Epub 2018 Jun 26.

引用本文的文献

1
Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review.优化孤立肾肿瘤患者肾部分切除术的治疗效果:一项非系统性综述
J Med Life. 2025 Apr;18(4):270-276. doi: 10.25122/jml-2025-0066.

本文引用的文献

1
Comparison between minimally invasive partial nephrectomy and open partial nephrectomy for complex renal tumors: a systematic review and meta-analysis.微创部分肾切除术与开放性部分肾切除术治疗复杂肾肿瘤的比较:系统评价和荟萃分析。
Int J Surg. 2023 Jun 1;109(6):1769-1782. doi: 10.1097/JS9.0000000000000397.
2
The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines.SCARE 2023 指南:更新共识外科病例报告(SCARE)指南。
Int J Surg. 2023 May 1;109(5):1136-1140. doi: 10.1097/JS9.0000000000000373.
3
Perioperative, functional, and oncologic outcomes of robot-assisted versus open partial nephrectomy for complex renal tumors (RENAL score ≥ 7): an evidence-based analysis.
机器人辅助与开放部分肾切除术治疗复杂肾肿瘤(RENAL 评分≥7)的围手术期、功能和肿瘤学结果:基于证据的分析。
J Robot Surg. 2023 Aug;17(4):1247-1258. doi: 10.1007/s11701-023-01565-3. Epub 2023 Mar 13.
4
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer.法国 AFU 癌症委员会指南 - 更新 2022-2024 年:肾癌管理。
Prog Urol. 2022 Nov;32(15):1195-1274. doi: 10.1016/j.purol.2022.07.146.
5
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南:2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
6
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).肾细胞癌部分肾切除术后局部复发的经皮消融与手术切除:倾向评分分析(REPART研究-UroCCR 71)
Eur Urol Focus. 2022 Jan;8(1):210-216. doi: 10.1016/j.euf.2021.02.007. Epub 2021 Feb 20.
7
Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence.肾细胞癌:根治性手术对局部或远处复发不同模式的作用。
Surg Oncol. 2020 Dec;35:106-113. doi: 10.1016/j.suronc.2020.08.002. Epub 2020 Aug 13.
8
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.临床 T1 期肾细胞癌肾部分切除术复发的预测因素:单中心 1227 例回顾性研究。
Int J Clin Oncol. 2020 May;25(5):892-898. doi: 10.1007/s10147-020-01632-x. Epub 2020 Feb 11.
9
Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.胰腺转移瘤切除术:一家三级医疗中心 20 年的经验。
Eur J Surg Oncol. 2020 May;46(5):825-831. doi: 10.1016/j.ejso.2019.11.514. Epub 2019 Nov 28.
10
Systematic Review of the Management of Local Kidney Cancer Relapse.局部肾癌复发的治疗方法系统评价。
Eur Urol Oncol. 2018 Dec;1(6):512-523. doi: 10.1016/j.euo.2018.06.007. Epub 2018 Jul 13.